ArticleJournal of the Chinese Medical Association : JCMA2020

Mir-25 is a potential treatment target for myocardial ischemic-reperfusion injury.

Shang-Feng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.